MIFLONID 200
200MCG INH PLV CPS DUR 120
SÚKL code | 0016304 |
---|---|
Name of the product | MIFLONID 200 |
_MA_MEDICATION_DETAIL_INFO_MED_NAME i | MIFLONID 200 |
Supplement | 200MCG INH PLV CPS DUR 120 |
Strenght | 200MCG |
Pharmaceutical form | Inhalation powder, hard capsule |
Package | 120 |
Route | Inhalation use |
Language of the pack | Czech |
Wrap type | Tablet container |
Legal status | na lékařský předpis |
Active substance | BUDESONIDE (BUDESONIDUM) |
ATC group | R03BA02 |
ATC group name | BUDESONID |
Marketing authorisation information
Registration Number | 14/ 232/00-C |
---|---|
Type of MA | National |
MA status | B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till) |
Placed on the market till | 31. 03. 2017 |
MA Holder | Novartis s.r.o., Praha |
MA Holder country | ČESKÁ REPUBLIKA |
Actual MA holder | Novartis s.r.o., Praha |
Actual MA holder country | ČESKÁ REPUBLIKA |